Network

Networks

Network News

27 Feb 2019

Fighting Ebola on the front line: Amber Kunkel’s mission in the Democratic Republic of the Congo

The Research Journal of the Institut Pasteur published a captivating focus on Amber Kunkel’s experience in Democratic Republic of the Congo, from the outbreak that ended in July 2018 to the epidemic currently raging.

She left for the Democratic Republic of the Congo on July 5, 2018 in response to the WHO’s call for international help. “We offered epidemiologists, laboratory scientists, and anthropologists to deploy through WHO’s Global Outbreak Alert and Response Network (GOARN) within days after they released a Request for Assistance,” explains Dr. Eileen Farnon, head of the OITF, a program that has been coordinating outbreak responses by scientists across the Institut Pasteur International Network since 2015. WHO gave the green light to Dr. Kunkel’s mission, “so she could provide her expertise to the final stage of the response.” [...]

Read the entire article online

Dr. Kunkel is a post-doctoral fellow and a key member of the Pasteur Outbreak Investigation Task Force (OITF). She will be in Phnom Penh, Cambodia, alongside Dr. Eileen Farnon, in March to share her knowledge during the Introduction to Outbreak Investigation and Response course co-organized by HKU-Pasteur. 

Between field missions, Dr. Amber Kunkel (right) with Dr. Eileen Farnon (left), head of the Outbreak Investigation Task Force on the Institut Pasteur campus in Paris, in January 2019. © Institut Pasteur/François Gardy.

08 Feb 2019

Tot binnenkort Tami!

After five years at HKU-Pasteur, Tami Zhang is leaving Hong Kong for the Netherlands to join an inspiring new lab.

Earlier this year, she joined Artemis One Health, in Delft, as a postdoctoral research fellow, involved in an Horizon 2020 project named Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain

IM2PACT aims to further the understanding of the blood-brain barrier (BBB) in health and disease states towards the development of innovative brain delivery systems, especially for biopharmaceuticals, such as peptides and antibodies, and the identification of novel disease drug targets for the treatment of the Alzheimer disease, Multiple Sclerosis and metabolic diseases. This project is sponsored by the European union (EU) and the European Federation of Pharmaceutical Industries and Association (EFPIA), within the context of the European framework for research and innovation. It involves the cooperation among 28 different partners belonging to 15 different European countries. 

Tami’s task in Artemis One Health will be to elucidate molecular mechanism that regulates neurotropic flavivirus transport at the BBB.

We are all very excited for this new adventure, and very proud of her achievements during all those years together in HKU-Pasteur. 

See you soon Tami, you are always welcome here! 

Tot binnenkort!